Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include sometimes findings: Enlarged liver (hepatomegaly). 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Enlarged liver (hepatomegaly), Jaundice, Enlarged spleen (splenomegaly) |
Blood and immune system |
No clinical trials have been registered for hyperbilirubinemia, shunt, primary.
3 publications have been identified in PubMed for hyperbilirubinemia, shunt, primary. Research spans Case Report / Case Series (67%) and Other (33%).
Kow AW (2024). [PMID: 40635854](https://pubmed.ncbi.nlm.nih.gov/40635854/). *ILIVER*. [Other]
Al Akko M (2024). [PMID: 39445286](https://pubmed.ncbi.nlm.nih.gov/39445286/). *Cureus*. [Case Report / Case Series]
Whitman RE (2024). [PMID: 38684471](https://pubmed.ncbi.nlm.nih.gov/38684471/). *Vet Clin Pathol*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
3 |
Anemia of inadequate production, Increased immature red blood cells (reticulocytosis), Enlarged spleen (splenomegaly) |
Lab test results | 1 | Hyperbilirubinemia |
Prenatal/birth | 1 | Anemia of inadequate production |
AI-curated news mentioning hyperbilirubinemia, shunt, primary
Updated Sep 9, 2026
A case report highlights a possible interaction between the gut-selective antibiotic rifaximin and carvedilol, leading to transient indirect hyperbilirubinemia. This finding may have implications for patient management in those receiving these medications.